New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 11, 2014
09:15 EDTBSDMBSD Medical reports initiation of clinical study using MicroThermX system
BSD Medical announced initiation of a clinical study by the University of Utah School of Medicine using BSD’s MicroThermX Microwave Ablation System to treat liver tumors. The study is a prospective, non-randomized, single arm trial that involves 20 patients. The study objective is to clinically evaluate the size of the ablation zones produced in liver tissue by BSD’s patented Synchronous Wave Alignment technology developed for MicroThermX. Both cirrhotic and non-cirrhotic liver tissue will be evaluated in this clinical study. The study is open for patient enrollment at the University of Utah School of Medicine. The principal investigator for the study is Ryan O’Hara, M.D., Assistant Professor of Radiology, Chief, Department of Interventional Radiology, Director of Interventional Oncology, University of Utah School of Medicine, Huntsman Cancer Hospital. “This trial will allow us to study the effects of the Synchronous Wave Alignment technology in both cirrhotic and non-cirrhotic liver tissue, and to determine if there is a difference in how the energy is absorbed in the two types of tissue,” stated Dr. O’Hara.
News For BSDM From The Last 14 Days
Check below for free stories on BSDM the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
August 13, 2014
09:16 EDTBSDMBSD Medical announces receipt of Nasdaq notice of bid price deficiency
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use